Добірка наукової літератури з теми "Cyclophosphamide"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cyclophosphamide".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cyclophosphamide"
&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 369 (September 1991): 7. http://dx.doi.org/10.2165/00128415-199103690-00025.
Повний текст джерела&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 375 (November 1991): 6. http://dx.doi.org/10.2165/00128415-199103750-00027.
Повний текст джерела&NA;. "Cyclophosphamide see Carboplatin/cyclophosphamide." Reactions Weekly &NA;, no. 380 (December 1991): 4. http://dx.doi.org/10.2165/00128415-199103800-00015.
Повний текст джерела&NA;. "Cyclophosphamide see Indomethacin/cyclophosphamide." Reactions Weekly &NA;, no. 283 (January 1990): 4. http://dx.doi.org/10.2165/00128415-199002830-00011.
Повний текст джерела&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 324 (October 1990): 4. http://dx.doi.org/10.2165/00128415-199003240-00014.
Повний текст джерела&NA;. "Cyclophosphamide see Prednisone/cyclophosphamide." Reactions Weekly &NA;, no. 343 (March 1991): 4. http://dx.doi.org/10.2165/00128415-199103430-00018.
Повний текст джерела&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 358 (July 1991): 7. http://dx.doi.org/10.2165/00128415-199103580-00028.
Повний текст джерела&NA;. "Cyclophosphamide see Chlorambucil/cyclophosphamide/methotrexate." Reactions Weekly &NA;, no. 348 (April 1991): 7. http://dx.doi.org/10.2165/00128415-199103480-00024.
Повний текст джерела&NA;. "Cyclophosphamide." Reactions Weekly &NA;, no. 1380 (December 2011): 15. http://dx.doi.org/10.2165/00128415-201113800-00053.
Повний текст джерела&NA;. "Cyclophosphamide." Reactions Weekly &NA;, no. 1384 (January 2012): 21. http://dx.doi.org/10.2165/00128415-201213840-00081.
Повний текст джерелаДисертації з теми "Cyclophosphamide"
Levy, Karine. "Toxicité du cyclophosphamide." Paris 5, 1993. http://www.theses.fr/1993PA05P156.
Повний текст джерелаAfsharian, Parvaneh. "Optimization of cyclophosphamide therapy based on pharmacogenetics /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-997-1/.
Повний текст джерелаYule, S. M. "The clinical pharmacology of cyclophosphamide in children." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309831.
Повний текст джерелаChanellière, Christiane. "Intérêt de l'utilisation du cyclophosphamide dans le traitement des pemphigoi͏̈des bulleuses et des pemphigus." Montpellier 1, 1989. http://www.theses.fr/1989MON11064.
Повний текст джерелаBelfayol-Pisanté, Laurence. "Evaluation d'un index prédictif de l'apparition des effets secondaires liés au traitement par le cyclophosphamide chez des patients atteints de vascularites et de collagénoses." Paris 5, 2000. http://www.theses.fr/2000PA05P629.
Повний текст джерелаCyclophosphamide is an alkylating agent widely used for the treatment of malignant dis eases. It also has been used to treat systemic vasculitides. This immunosuppressive therapy, given in association with corticosteroids, has markedly improved the prognosis of these diseases. Although the pharmacokinetics of cyclophosphamide in cancer patients have been well documented, no information has been reported on cyclophosphamide pharmacokinetics in patients with systemic vasculitis and connectivitis. The aim of this study was to evaluate the concentrations and pharmacokinetic parameters of cyclophosphamide and its key circulating intermediate metabolite, 4-hydroxycyclophosphamide/aldophosphamide, in these patients and to define a relationships between pharmacokinetic parameters and toxic effects. The results are consistent with those obtained for cancer patients, in spite of a wide inter-patient variability of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide concentrations in our study [. . . )
Lo, Kwun-hang Kenny. "Effects of cyclophosphamide on ulcer in rat stomachs /." View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30708825.
Повний текст джерела盧冠恆 and Kwun-hang Kenny Lo. "Effects of cyclophosphamide on ulcer in rat stomachs." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B45010158.
Повний текст джерелаMaynard-Faure, Patricia. "Synthèse d'analogues bicycliques préactives du cyclophosphamide et de l'aldophosphamide." Lyon 1, 1997. http://www.theses.fr/1997LYO10268.
Повний текст джерелаLu, Hong. "Pharmacokinetic and drug metabolism studies of cyclophosphamide and ifosfamide /." The Ohio State University, 1998. http://rave.ohiolink.edu/etdc/view?acc_num=osu148795015360318.
Повний текст джерелаLi, Zhaoyang. "DNA alkylation by active metabolites of Cyclophosphamide and Ifosfamide /." The Ohio State University, 1999. http://rave.ohiolink.edu/etdc/view?acc_num=osu1488192960169091.
Повний текст джерелаКниги з теми "Cyclophosphamide"
Boche, Gernot. Cyclopropane derived reactive intermediates. Chichester: Wiley, 1990.
Знайти повний текст джерелаAsli-Yalfani, Esmael. Cellular and molecular studies of the immunopharmacology of cyclophosphamide. Manchester: University of Manchester, 1995.
Знайти повний текст джерелаAzria, M. (Moïse). Calcitonins: Physiological and pharmacological aspects. Berlin: Springer Verlag, 1989.
Знайти повний текст джерелаLewtas, Joellen. Final report on the evaluation of four toxic chemicals in an In Vivo/In Vitro toxicological screen--acrylamide, chlordecone, cyclophosphamide, and diethylstilbestrol. Research Triangle Park, N.C: U.S. Environmental Protection Agency, Health Effects Research Laboratory, 1986.
Знайти повний текст джерелаBlokdijk, G. J. Cyclophosphamide; The Ultimate Step-By-Step Guide. CreateSpace Independent Publishing Platform, 2018.
Знайти повний текст джерелаR, Nowrousian M., ed. Ifosfamide in cancer therapy: A comparison with cyclophosphamide. Jena: Universitätsverlag, 1993.
Знайти повний текст джерелаCyclophosphamide: Clinical Pharmacology, Uses and Potential Adverse Effects. Nova Science Publishers, Incorporated, 2015.
Знайти повний текст джерелаPublications, ICON Health. Cyclophosphamide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.
Знайти повний текст джерелаChen, Chu-liang. Identification of an inguinal adipocyte-specific protein using monoclonal antibody selected by cyclophosphamide. 1992.
Знайти повний текст джерелаProgress in Clinical Biochemistry and Medicine. Springer Verlag, 1989.
Знайти повний текст джерелаЧастини книг з теми "Cyclophosphamide"
Maxwell, Robert A., and Shohreh B. Eckhardt. "Cyclophosphamide." In Drug Discovery, 265–80. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0469-5_20.
Повний текст джерелаMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents, 155–59. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_22.
Повний текст джерелаSchwab, Manfred. "Cyclophosphamide." In Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1439-2.
Повний текст джерелаBartlett, R. R. "Cyclophosphamide." In Handbook of Experimental Pharmacology, 453–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73217-1_20.
Повний текст джерелаScorer, Matthew, Olga Golberg, and Karen Harman. "Cyclophosphamide." In Handbook of Systemic Drug Treatment in Dermatology, 112–19. 3rd ed. London: CRC Press, 2022. http://dx.doi.org/10.1201/9781003016786-16.
Повний текст джерелаCurtis, John J. "Cyclophosphamide." In Immunotherapy in Transplantation, 290–95. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444355628.ch19.
Повний текст джерелаMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents, 92–94. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_15.
Повний текст джерелаde Groot, Anton C. "Cyclophosphamide." In Monographs In Contact Allergy, 342. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-160.
Повний текст джерелаNeumann, Ron. "Cyclophosphamide." In Intraocular Inflammation, 323–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-540-75387-2_24.
Повний текст джерелаSaxena, Ajit Kumar, and Amit Kumar. "Introduction of Cyclophosphamide." In Fish Analysis for Drug and Chemicals Mediated Cellular Toxicity, 1–5. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4700-3_1.
Повний текст джерелаТези доповідей конференцій з теми "Cyclophosphamide"
Kobrová, Kateřina, Lenka Minxová, Jakub Zieg, Sylva Skálová, and Pavla Doležalová. "AB0998 SEVERE IGA VASCULITIS: CYCLOPHOSPHAMIDE IN QUESTION." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6731.
Повний текст джерелаErtenli, Ý., V. Cobankara, S. Apras, S. Kiraz, MA Oztürk, and M. Çalgüneri. "AB0079 Cyclophosphamide exposure during pregnancy: two cases." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.124.
Повний текст джерелаVIEIRA, ADAH SOPHIA RODRIGUES, GUILHERME LOPES PEREIRA, ANTÔNIO JOSÉ DA SILVA NETO, ALINE DE CASTRO CARACAS, RODRIGO BARBOSA DE AZEVEDO, and REJANE MARIA RODRIGUES DE ABREU VIEIRA. "RITUXIMAB IN POLYARTERITIS CYCLOPHOSPHAMIDE INTOLERANT NODOSE: CASE REPORT." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-231.
Повний текст джерелаTanaka, N., A. Hirano, H. Inoue, K. Ogura, A. Hattori, N. Jibiki, H. Yukawa, et al. "Abstract OT1-01-02: A phase II trial of neoadjuvant docetaxel/cyclophosphamide followed by epirubicin/cyclophosphamide for triple-negative breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-ot1-01-02.
Повний текст джерелаConstantin, Mirela Alina, Lucian Alexandru Constantin, Nicolae Ionut Cristea, and Ines Nitoi. "INFLUENCE OF TiO2 DOPANT TYPE UPON CYCLOPHOSPHAMIDE DEGRADATION EFFICIENCY." In International Symposium "The Environment and the Industry". National Research and Development Institute for Industrial Ecology, 2017. http://dx.doi.org/10.21698/simi.2017.0003.
Повний текст джерелаSon, R., D. Hwang, AH Jung, JM Lim, SH Jung, SY Suh, HJ Hahn, YS Cho, EJ Park, and HI Cheong. "5PSQ-082 Cyclophosphamide therapy in children with nephrotic syndrome." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.436.
Повний текст джерелаChalwadi, U. K., M. Pertzborn, N. Swamy, and A. Agarwal. "Cyclophosphamide-Induced Late Onset Pulmonary Fibrosis in Pediatric Patient." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3263.
Повний текст джерелаKong, Chia Wei, Oluwatobi Adeagbo, Robert Hooper, Vanessa Titmuss, and Suresh Babu. "Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2982.
Повний текст джерелаYamauchi, Kensuke, Meng Yang, Katsuhiro Hayashi, Ping Jiang, Mingxu Xu, Norio Yamamoto, Hiroyuki Tsuchiya, et al. "Imaging enhancement of malignancy by cyclophosphamide: surprising chemotherapy opposite effects." In Biomedical Optics (BiOS) 2008, edited by Alexander P. Savitsky, Robert E. Campbell, and Robert M. Hoffman. SPIE, 2008. http://dx.doi.org/10.1117/12.772085.
Повний текст джерелаDaillere, Romain, Marie Vetizou, and Laurence Zitvogel. "Abstract 4928: Impact ofE. hiraeon the tumoricidal activity of cyclophosphamide." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4928.
Повний текст джерелаЗвіти організацій з теми "Cyclophosphamide"
Lao, Lixing, and Richard H. Wong. The Effect of Electroacupuncture on Cyclophosphamide-Induced Emesis in Ferrets. Fort Belvoir, VA: Defense Technical Information Center, July 1995. http://dx.doi.org/10.21236/ada299200.
Повний текст джерелаYin, Xietian, Shichao Zhao, Nan Xiang, Jidong Chen, Jun Xu, and Yudan Zhang. Efficacy and Safety of Chinese Herbal Medicines combined with Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0010.
Повний текст джерелаZhang, LiBo, GuangZhen Liu, and YanChuang Liang. Meta analysis of traditional Chinese medicine combined with cyclophosphamide in the treatment of adult refractory nephrotic syndrome. International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0020.
Повний текст джерелаEmens, Leisha A., and Elizabeth M. Jaffee. Enhancement of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine by Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. Fort Belvoir, VA: Defense Technical Information Center, June 2003. http://dx.doi.org/10.21236/ada417167.
Повний текст джерела